A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

Human tuberculosis remains a significant cause of mortality and morbidity throughout the world. The global economic impact of bovine TB is considerable. An effective vaccine would be the most cost-effective way to control both epidemics, particularly in emerging economies. TB vaccine research would benefit from the identification of an immune correlate of protection with which vaccines could be gated at both preclinical and clinical levels. In-vitro mycobacterial growth inhibition assays (MGIA) are functional assays that include most aspects of the complex host immune response to mycobacteria, and they may serve as functional immune correlates for vaccine development.

Source: Tuberculosis - July 22, 2017 Category: Respiratory Medicine Authors: Ilaria Pepponi, Bhagwati Khatri, Rachel Tanner, Bernardo Villarreal-Ramos, Martin Vordermeier, Helen McShane Source Type: research